Lisofylline
![Skeletal formula of lisofylline](/Images/godic/202501/24/Lisofylline.svg5415.png")
![Space-filling model of the lisofylline molecule](/Images/godic/202501/24/Lisofylline_3D_spacefill5415.png")
![Lisofylline synthesis: U.S. Patent 5,567,704 NB[1][2][3][4][5][6][7]](/Images/godic/202501/24/Lisofylline_synthesis.svg5415.png")
Lisofylline (LSF) is a synthetic small molecule with novel anti-inflammatory properties. LSF can effectively prevent type 1 diabetes in preclinical models and improves the function and viability of isolated or transplanted pancreatic islets. It is a metabolite of pentoxifylline.